490 Results (Page 12 of 20)
Canada Markets Research Reports
Canada Addiction Therapeutics Market Analysis
Canada addiction therapeutics market was valued at $808 Mn in 2022 and is estimated to reach $1378 Mn in 2030, exhibiting a CAGR of 6.9% during the forecast period. One of the key elements driving development in the addiction therapeutics market is increase in drug awareness campaigns and addiction & rehab centres among the population. Leading key players functioning in the market include Alkremes, Teva Pharmaceutical Industries, Glenmark Pharmaceuticals, Titan Pharmaceuticals, Pfizer, Inc., GSK, Johnson & Johnson, Perrigo, Cipla, Hikma Pharmaceuticals, Dr. Reddy’s Laboratories Limited, Indivior, and Mylan N.V
Canada Actinic Keratosis Therapeutic Market Analysis
Canada actinic keratosis therapeutic market is anticipated to experience growth from $544 Mn in 2022 to $798 Mn by 2030, with a CAGR of 4.9% during the forecast period of 2022-2030. This market is driven by the rising prevalence of the condition supported by favourable reimbursement policies and the growing demand for minimally invasive procedures due to the advancements in technology. The market exhibits a moderate concentration due to the presence of key players such as Leo Pharma, Cipher Pharmaceuticals, 3M Canada, Valeant Pharmaceuticals, Sun Pharmaceuticals, Biofrontera, Bausch Health, among others.
Canada Sleep Disorders Market Analysis
This report presents a strategic analysis of the Canada Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Sleep Disorders Market, offering unmatched value, accuracy, and expert insights.
Canada Oncology Drugs Market Analysis
By 2030, it is anticipated that the Canadian oncology drugs market will reach a value of $46 Mn from $15.7 Mn in 2022. The Canadian oncology drugs market would likely grow at a CAGR of 11.6% during 2022-30. The companies operating in the oncology drug in Canada market are AstraZeneca Plc. GlaxoSmithKline, Eli Lilly & Co., Roche Diagnostics, Novartis AG, Pfizer Inc., Merck & Co., Gilead, Sanofi S.A, and Celgene Corporation. The Canadian oncology drugs market is segmented based on therapy modality and types of cancer. Key factors for market growth in the oncology market can be the high rise in cancer cases, increasing research on the oncology sectors, and so on.
Canada Oncology Clinical Trials Market Analysis
This report presents a strategic analysis of the Canada Oncology Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Oncology Clinical Trials Market, offering unmatched value, accuracy, and expert insights.
Canada Lung Cancer Therapeutics Market Analysis
Canada's lung cancer therapeutics market is likely to grow at a CAGR of 8.11% from a market size of $2.34 Bn in 2022 to $4.44 Bn in 2030. One of the main factors propelling the growth of the lung cancer treatments market is the increase in the adoption of unhealthy lifestyles, such as smoking. Lung cancer is known to be frequently caused by cigarette smoking. This report is segmented by type, therapy, type of molecule, drug class, and distribution channel. Some key players in this market include Sanofi, Bristol-Myers & Squibb, Pfizer, AstraZeneca, Celgene Corporation, Boehringer Ingelheim, J&J, and others.
Canada Lung Cancer Drugs Market Analysis
Canada's Lung Cancer Drug Market is projected to grow from $0.765 Bn in 2022 to $1.447 Bn by 2030, registering a CAGR of 8.3% during the forecast period of 2022–30. The use of personalized medicine, which tailors treatment to the specific characteristics of a patient's cancer, is also driving growth in the lung cancer drug market in Canada. Key players in the market include Pfizer, AstraZeneca, Novartis, and Bristol-Myers Squibb.
Canada Infectious Disease Therapeutics Market Analysis
Canada's infectious disease therapeutics market is likely to grow at a CAGR of 4.35% from a market size of $9.59 Bn in 2022 to $13.48 Bn in 2030. The increase in the prevalence of infectious diseases in Canada and the increasing government initiatives to provide facilities to patients have acted as a market growth driver. This report is segmented by mode of treatment, applications, disease type, target organisms, and end user. Some key players in this market include Novartis, Roche, Janssen Pharmaceutical, Merck, BI, and others.
Canada ECG Equipments Market Analysis
This report presents a strategic analysis of the Canada ECG Equipments Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada ECG Equipment Market, offering unmatched value, accuracy, and expert insights.
Canada Diabetes Drugs Market Analysis
Canada's diabetes drugs market size was valued at $4.94 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.1% from 2022 to 2030 and will reach $7.93 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The Canadian diabetes drug market will grow as the Canadian population continues to age, and the incidence of diabetes is expected to increase. The key market players are Insulet Corporation, Sanofi, Johnson & Johnson, Abbott, Bayer Pharmaceuticals, Novo Nordisk, and others.
Canada Diabetes Devices Market Analysis
This report presents a strategic analysis of the Canada Diabetes Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Diabetes Devices Market, offering unmatched value, accuracy, and expert insights.
Canada Depression Therapeutics Market Analysis
This report presents a strategic analysis of the Canada Depression Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Depression Therapeutics Market, offering unmatched value, accuracy, and expert insights.
Canada Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis
This report presents a strategic analysis of the Canada Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy, and expert insights.
Canada Cardiac Surgery Instruments Market Analysis
This report presents a strategic analysis of the Canada Cardiac Surgery Instruments Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canada Cardiac Surgery Instruments Market, offering unmatched value, accuracy, and expert insights.
Canada Blockchain Technology in Healthcare Market Analysis
This report presents a strategic analysis of Canada's Blockchain Technology in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about Canada's Blockchain Technology in the Healthcare Market, offering unmatched value, accuracy, and expert insights.
Canada Biosimilars Market Analysis
Canada's biosimilar market size was valued at $1.53 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 22.2% from 2022 to 2030 and will reach $7.63 Bn in 2030. The market is segmented by product type and indication type. This market will grow as there is a shortage of qualified radiologists and imaging technologists in some areas, leading to longer wait times and delays in diagnosis and treatment. The key market players are Sonic Healthcare Limited Amgen, Biocon, Celltrion Healthcare, Dr. Reddy's Laboratories, and others.
Canada Biomaterials in Healthcare Market Analysis
Canada's biomaterials in the healthcare market are likely to grow at a CAGR of 13.20% from a market size of $12.5 Bn in 2022 to $33.7 Bn in 2030. Market growth is driven mainly by factors such as increasing demand for medical implants and the sudden rise in cardiovascular diseases. This report is segmented by type and by application. Some key players in this market include Celanese Corporation, Berkeley Advanced Biomaterials, Stryker Corporation, Zimmer Biomet Holdings, and others.
Canada Anti-Depressants Drugs Market Analysis
Canada's Anti-depressant drugs market size was valued at $1.31Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.9% from 2022-30 and will reach $2.08 Bn in 2030. The market is segmented by drug class, indication, route of administration, end-user, and distribution channel. The Canadian anti-depressant drug market will grow because of the development of novel antidepressant drugs and the expansion of the product portfolio of pharmaceutical companies. The key market players are Apotex Inc., Lundbeck Canada Inc., Purdue Pharma Canada, Janssen Inc., Paladin Labs Incand others.
Canada ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
This report presents a strategic analysis of the Canadian ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Canadian ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market, offering unmatched value, accuracy, and expert insights.
Canada 3D Printing Medical Devices Market Analysis
Canada's 3D printing medical devices market size was valued at $238 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 16.3% from 2022 to 2030 and will reach $ 795 Mn in 2030. The market is segmented by component, application, technology, and end user. The Canadian 3D Printing Medical Devices market will grow as the development of new 3D printing materials and techniques has led to the production of more complex and customizable medical devices. The key market players are Precision ADM (CAN), Custom Prototypes Inc. (CAN), Adaptiiv Medical Technologies Inc. (CAN), 3D Metalforge Inc. (CAN), 3DQue Systems Inc. (CAN), Mosaic 3D Printing (CAN), Nia Technologies Inc. (CAN), and others.
Canada 3D Imaging Market Analysis
Canada's 3D Imaging market is projected to grow from $ 2.43 Bn in 2022 to $ 8.25 Bn by 2030, registering a CAGR of 16.5% during the forecast period of 2022-30. The market will be driven by the increasing aging population and rise of chronic conditions generating higher demand for early diagnostic and precise treatments. The market is segmented by product, application, end-user, and by portability. Some of the major players include GE Healthcare, Canon Inc. & Philips Healthcare.
Canada Over The Counter (OTC) Pharmaceuticals Market Analysis
Canada's over-the-counter (OTC) pharmaceuticals market size was valued at $11000 Mn in 2022 and is estimated to expand at a CAGR of 5.54% from 2022 to 2030 and will reach $16932.8 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
Canada Alzheimer’s Disease Drugs Market Analysis
Canada's Alzheimer’s disease drugs market was valued at $1.23 Bn in 2022 and is estimated to expand at a CAGR of 8.42% from 2022-30 and will reach $2.35 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Pfizer, Biogen, Eli Lilly and Company, Novartis International AG, Merck & Co, AstraZeneca, Roche Holding AG, Johnson & Johnson, AbbVie, and Sanofi among others.
Canada Alexipharmic Drugs Market Analysis
Canada Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 4.70% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The Canada Alexipharmic Drugs market will grow because As Canadians become more health-conscious, there is a growing demand for prescription medications to treat chronic conditions such as diabetes, depression, and high blood pressure. The key market players are Pfizer Inc., Merck & Co., Inc., Pfizer Inc., Bausch Health Companies Inc and others.
Canada Oral Care Market Analysis
Canada's oral care market was valued at $2.8 Bn in 2022 and is estimated to expand at a CAGR of 6.2% from 2022 to 2030 and will reach $4.5 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the aging population. The market is segmented by type, drug, and distribution channel. Sun Pharmaceutical Industries, Altima Dental, Dental Solutions, Millenium Dental, Dentalcorp, and 123Dentist are some of the key players in this market.